7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $2.1B | $23M | 0.0% | 1.6% | — | — | $480M |
| 2024 | $1.7B | $14M | 0.0% | 1.0% | — | — | $491M |
| 2023 | $1.7B | $23M | 0.0% | 1.2% | $81M | — | $390M |
| 2022 | $1.4B | -$9M | 0.0% | -1.4% | $47M | — | $348M |
| 2021 | $966M | -$188M | 0.0% | -22.5% | $55M | — | $321M |
| 2020 | $817M | $31M | 0.0% | 3.1% | $39M | — | $85M |
| 2019 | $786M | $8M | 0.0% | 2.0% | $19M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $604M | $3M | 0.0% | 1.2% | — | — | $420M |
| Dec '25 | $541M | $9M | 0.0% | 2.1% | — | — | $480M |
| Sep '25 | $580M | $7M | 0.0% | 2.5% | — | — | $441M |
| Jun '25 | $521M | $3M | 0.0% | 0.6% | — | — | $390M |
| Mar '25 | $480M | $4M | 0.0% | 1.1% | — | — | $469M |
| Dec '24 | $461M | $4M | 0.0% | 1.1% | — | — | $491M |
| Sep '24 | $438M | $4M | 0.0% | 1.3% | — | — | $422M |
| Jun '24 | $422M | $3M | 0.0% | 1.2% | — | — | $387M |
| Mar '24 | $415M | $3M | 0.0% | 0.2% | — | — | $351M |
| Dec '23 | $441M | $3M | 0.0% | 0.3% | $64M | — | $390M |
| Sep '23 | $417M | $6M | 0.0% | 1.3% | $22M | — | $330M |
| Jun '23 | $413M | $7M | 0.0% | 1.7% | $8M | — | $318M |
| Mar '23 | $386M | $7M | 0.0% | 1.7% | -$13M | — | $311M |
| Dec '22 | $364M | $18M | 0.0% | 0.6% | $29M | — | $348M |
| Sep '22 | $343M | $2M | 0.0% | -1.3% | $16M | — | $317M |
| Jun '22 | $336M | -$10M | 0.0% | -1.6% | $7M | — | $292M |
| Mar '22 | $314M | -$18M | 0.0% | -3.7% | -$5M | — | $316M |
| Dec '21 | $275M | -$12M | 0.0% | -7.0% | -$12M | — | $321M |
| Sep '21 | $252M | -$9M | 0.0% | -5.1% | $62M | — | $362M |
| Jun '21 | $226M | -$173M | 0.0% | -85.6% | $7M | — | $300M |
How the market has priced PRVA against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Privia Health Group, Inc.'s revenue has grown 21.0% per year, and net income declined 6.0% per year. These are computed facts, not advice.
As of FY2025, Privia Health Group, Inc. reported — of total debt against $480M of cash.
In FY2025, gross margin was —, operating margin 1.6%, and net margin 1.1%.
As of Jun '26, Privia Health Group, Inc. traded at a price-to-earnings ratio of about 134.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.